US Stock MarketDetailed Quotes
AKTX Akari Therapeutics
- 2.3150
- -0.1150-4.73%
Close Nov 6 16:00 ET
28.11MMarket Cap-786P/E (TTM)
2.4300High2.2100Low9.70KVolume2.4300Open2.4300Pre Close22.67KTurnover0.18%Turnover RatioLossP/E (Static)12.14MShares4.400052wk High-7.59P/B12.64MFloat Cap1.077552wk Low--Dividend TTM5.46MShs Float5000.0000Historical High--Div YieldTTM9.05%Amplitude1.0775Historical Low2.3370Avg Price1Lot Size
Akari Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -4.26%-4.89M | 17.13%-4.04M | 23.59%-16.43M | 45.25%-4.69M | 3.36%-4.88M | -14.10%-21.5M | -76.21%-8.57M | 31.93%-5.05M | -11.19%-18.85M | -18.21%-5M |
| Net income from continuing operations | -88.95%-7.56M | -656.04%-5.57M | 43.61%-10.01M | 29.58%-4M | 119.34%1M | -1.86%-17.75M | -30.68%-5.68M | 11.34%-5.18M | -2.01%-17.42M | 15.00%-5.79M |
| Operating gains losses | 127.97%167K | 93.11%-385K | -28.91%-6.85M | -1,002.66%-597K | -6,679.83%-5.58M | -2,292.55%-5.32M | 23.60%-54.14K | -131.02%-82.36K | 123.15%242.5K | 130.44%49.21K |
| Depreciation and amortization | --0 | 1,200.00%13K | 0.00%4K | 6.16%1K | -0.60%1K | -3.05%4K | -10.11%942 | -2.71%1.01K | -53.68%4.13K | 1.00%1.01K |
| Other non cash items | ---- | ---- | --142K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | 648.66%2.05M | 383.84%1.6M | -205.35%-866K | 87.38%-374K | -615.08%-563K | 141.44%822K | -457.39%-2.96M | 105.66%109.3K | -3,465.71%-1.98M | -75.28%656.9K |
| -Change in prepaid assets | 1,980.00%564K | 157.74%138K | -95.88%70K | 93.56%-30K | 46.03%-239K | 197.52%1.7M | -450.96%-465.62K | 28.99%-442.85K | -1,007.17%-1.74M | -215.98%-960.12K |
| -Change in payables and accrued expense | 532.56%1.49M | 550.62%1.46M | -6.73%-936K | 86.09%-344K | -158.68%-324K | -263.43%-877K | -272.24%-2.47M | 142.23%552.16K | 2.57%-241.31K | -11.59%1.62M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -4.26%-4.89M | 17.13%-4.04M | 23.59%-16.43M | 45.25%-4.69M | 3.36%-4.88M | -14.10%-21.5M | -76.21%-8.57M | 31.93%-5.05M | -11.19%-18.85M | -18.21%-5M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 2,567.70%7.76M | -52.86%1.51M | -72.24%7.02M | 291K | -74.03%3.21M | 76.93%25.29M | 0 | 12.37M | -43.00%14.29M | -81.37%1.12M |
| Net issuance payments of debt | --669K | ---215K | ---- | --0 | --0 | ---- | ---- | ---- | ---- | ---- |
| Net common stock issuance | 2,346.21%7.09M | -46.26%1.73M | -72.15%7.02M | --290K | -74.03%3.21M | 76.27%25.19M | --0 | --12.37M | -42.94%14.29M | -81.37%1.12M |
| Proceeds from stock option exercised by employees | --0 | --3K | -95.74%4K | --1K | --0 | --94K | ---- | ---- | --0 | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 2,567.70%7.76M | -52.86%1.51M | -72.24%7.02M | --291K | -74.03%3.21M | 76.93%25.29M | --0 | --12.37M | -43.00%14.29M | -81.37%1.12M |
| Net cash flow | ||||||||||
| Beginning cash position | -88.69%1.31M | -70.98%3.85M | 41.54%13.25M | -30.74%11.58M | 41.54%13.25M | -33.40%9.36M | 150.78%16.72M | -33.40%9.36M | 145.23%14.06M | 8.71%13.39M |
| Current changes in cash | 165.16%2.87M | -51.68%-2.53M | -348.73%-9.41M | 48.65%-4.4M | -122.80%-1.67M | 183.10%3.78M | -198.51%-8.57M | 198.63%7.32M | -156.06%-4.55M | -320.96%-3.89M |
| Effect of exchange rate changes | -200.00%-2K | ---5K | -93.33%7K | -16.81%2K | --0 | 174.61%105K | 152.68%2.4K | 44.45%44.38K | -170.18%-140.73K | -564.81%-142.28K |
| End cash Position | -41.83%4.18M | -88.69%1.31M | -70.98%3.85M | -11.90%7.18M | -30.74%11.58M | 41.54%13.25M | 114.98%8.15M | 150.78%16.72M | -33.40%9.36M | -33.40%9.36M |
| Free cash flow | -4.26%-4.89M | 17.13%-4.04M | 23.59%-16.43M | 45.25%-4.69M | 3.36%-4.88M | -14.10%-21.5M | -76.21%-8.57M | 31.93%-5.05M | -11.19%-18.85M | -18.21%-5M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data